WX

WuXi PharmaTech opts out of joint venture with Covance in China - 09/29 - 09:32 AM ET

WuXi PharmaTech Challenges Support On Increased Volume - 09/09 - 12:56 PM ET

WX: To Present At JPMorgan Asia Pacific Conference @ 08:00 ET [delayed] - 09/04 - 07:24 AM ET

WuXi PharmaTech names new vice president of synthetic chemistry - 08/25 - 11:02 AM ET

WuXi PharmaTech appoints Dr Rujian Ma as VP of synthetic chemistry - 08/25 - 10:18 AM ET

WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry - 08/22 - 11:48 AM ET

WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility - 08/17 - 07:59 AM ET

WX: Q2 Earnings Call @ 08:00 ET Today [delayed] - 08/14 - 07:22 AM ET

WuXi PharmaTech Announces Second Quarter 2008 Results - 08/13 - 06:00 PM ET

WuXi PharmaTech names new VP of business development - 08/05 - 09:10 AM ET

WuXi PharmaTech (NYSE: WX) Appoints Mr. Steven M. Hutchins as VP of Business Development - 08/01 - 01:32 AM ET

WuXi PharmaTech Sets Date to Release Second Quarter Financial Results - 07/31 - 02:54 AM ET

China In-Focus: WuXi PharmaTech Schedules August 13 Earnings Call - 07/25 - 05:59 PM ET

WuXi PharmaTech Schedules Second Quarter 2008 Earnings Release on Wednesday, August 13, 2008 - 07/24 - 04:30 PM ET

Warburg Pincus Tech announces investment in WuXi PharmaTech - 07/15 - 01:28 PM ET

Warburg Pincus acquires 5.4% of Wuxi PharmaTech shares - 07/14 - 04:49 PM ET

WARBURG PINCUS ACQUIRES 5.4% OF WUXI PHARMATECH SHARES - 07/14 - 04:39 PM ET

WARBURG PINCUS ACQUIRES 5.4% OF WUXI PHARMATECH FROM UNITED OVERSEAS - 07/14 - 04:37 PM ET

Warburg Pincus Acquires 5.4% of WuXi PharmaTech's Outstanding Ordinary Shares from United Overseas Bank - 07/14 - 04:30 PM ET

Dr. Richard M. Soll Joined WuXi PharmaTech (NYSE: WX) as VP of Medicinal Chemistry - 07/14 - 12:01 AM ET

Page 1 of 7     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index